| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |